如何评价华尔街日报说中国领导人正在考虑放松疫情管控措施？
from telegram 竹新社
知情人士透露，中国领导人正在考虑放松疫情管控措施，但进展缓慢，也没有设定时间表。
知情人士称，官员们已通知零售企业，核酸检测的频率最早可能在本月降低。部分原因是大规模检测成本高昂。政府正计划减少全国各地设立的数千个核酸检测站。
但知情人士表示，领导层发现今年很难出台更广泛的放松措施。许多管控措施仍将保留。北京方面担心，新的病毒变种，公共医疗体系设备不足以及即将到来的冬季可能使得感染、住院和死亡人数激增，从而削弱共产党执政的合法性。
知情人士说，中国卫生官员一直在密切关注香港、日本和韩国的死亡率和公众反应。“中国的重新开放将有序进行。它将根据地理区域和行业逐渐开展，不同于我们在西方看到的”。例如，政府可以决定在主要商业中心城市实施不那么严格的措施。
此外，知情人士还透露，中国官员近几个月来一直与世界卫生组织保持密切联系，重点关注世卫组织为新型肺炎疫情设定的警戒级别。级别改变将给中国的政策改变带来更大回旋余地。北京方面可能会开始推动采取更积极的宽松措施，并调整国内对新型肺炎的叙事。世卫组织一名官员说，该机构不会对与成员国的私下讨论发表评论。
（华尔街日报）
https://www.wsj.com/articles/china-weighs-zero-covid-exit-but-proceeds-with-caution-and-without-timeline-11667826209
华尔街日报成功预测常委名单，应该消息最靠谱了吧？
知情人士透露，中国领导人正在考虑放松疫情管控措施，但进展缓慢，也没有设定时间表。
知情人士称，官员们已通知零售企业，核酸检测的频率最早可能在本月降低。部分原因是大规模检测成本高昂。政府正计划减少全国各地设立的数千个核酸检测站。
但知情人士表示，领导层发现今年很难出台更广泛的放松措施。许多管控措施仍将保留。北京方面担心，新的病毒变种，公共医疗体系设备不足以及即将到来的冬季可能使得感染、住院和死亡人数激增，从而削弱共产党执政的合法性。
知情人士说，中国卫生官员一直在密切关注香港、日本和韩国的死亡率和公众反应。“中国的重新开放将有序进行。它将根据地理区域和行业逐渐开展，不同于我们在西方看到的”。例如，政府可以决定在主要商业中心城市实施不那么严格的措施。
此外，知情人士还透露，中国官员近几个月来一直与世界卫生组织保持密切联系，重点关注世卫组织为新型肺炎疫情设定的警戒级别。级别改变将给中国的政策改变带来更大回旋余地。北京方面可能会开始推动采取更积极的宽松措施，并调整国内对新型肺炎的叙事。世卫组织一名官员说，该机构不会对与成员国的私下讨论发表评论。
（华尔街日报）
https://www.wsj.com/articles/china-weighs-zero-covid-exit-but-proceeds-with-caution-and-without-timeline-11667826209
华尔街日报成功预测常委名单，应该消息最靠谱了吧？
原文：
China Weighs Zero-Covid Exit But Proceeds With Caution and Without Timeline
SINGAPORE—Chinese leaders are considering steps toward reopening after nearly three years of tough pandemic restrictions but are proceeding slowly and have set no timeline, according to people familiar with the discussions.
Chinese officials have grown concerned about the costs of their zero-tolerance approach to smothering Covid outbreaks, which has resulted in lockdowns of cities and whole provinces, crushing business activity and confining hundreds of millions of people at home for weeks and sometimes months on end. But they are weighing those against the potential costs of reopening on public health and support for the Communist Party.
As a result, they are proceeding cautiously despite the deepening impact of the Covid policies, the people said, pointing to a long path to anything approaching pre-pandemic levels of activity, with the timeline stretching to sometime near the end of next year.
The uncertainty around China’s Covid-19 strategy has led to a guessing game in the financial markets, with some looking for any sign that China would begin easing its Covid policies. China’s Communist Party congress last month, when Chinese leader Xi Jinping claimed a third term, had once been viewed as a potential turning point in its battle against Covid, but little has changed in the country’s approach to containing Covid.
China’s leaders are worried that a surge in Covid infections, hospital admissions and deaths could undermine confidence in the ruling Communist Party’s legitimacy.
PHOTO: TINGSHU WANG/REUTERS
On Saturday, officials from China’s National Health Commission again reaffirmed their commitment to a firm “zero-Covid” strategy, which they described as essential to “protect people’s lives.”
Some progress is being made on relaxing border controls for inbound travelers from abroad. Beijing is likely to further cut the number of hotel quarantine days required of incoming travelers by early next year, to a total of seven days, say people involved in discussions, from a current policy of seven days in a quarantine facility followed by three days of home monitoring.
Domestically, officials have informed retail businesses that the frequency of PCR testing—a staple of China’s Covid regime—could be reduced as soon as this month, in part because of the high cost of mass testing, according to people familiar with the matter. The people said the government is planning to reduce the thousands of PCR testing stations that have been set up across the country as part of the campaign to institutionalize testing, citing the cost.
Still, the leadership has found it difficult to enact broader relaxation measures this year, the people said. Many of the measures will remain. The country will still move aggressively to stamp out even small outbreaks, through mass testing and lockdowns. People will still need to use health codes on their phones to access public spaces, and travelers entering the country will face quarantines and rounds of Covid tests.
A combination of new viral variants, an underequipped public healthcare system and the impending approach of winter has left Beijing worried that a potential surge in Covid infections, hospital admissions and deaths could undermine confidence in the ruling Communist Party’s legitimacy.
Chinese health officials have been closely monitoring the fatality rates and public reactions in Hong Kong, Japan and South Korea, which share cultural roots with China and where governments had until recently imposed similar measures, the people said.
“The reopening in China will be carried out in an orderly manner. It will start gradually depending on the geographic areas and sectors, and it will be different from what we’ve seen in the West,” said one of the people involved in discussions. For example, the government could decide to implement less stringent measures in cities that are major business hubs.
While some have questioned the accuracy of China’s official figures, health experts say the country’s Covid fatality rate has been much lower than in much of the West due to its strict measures. Officially, China has recorded roughly 5,000 Covid-19 deaths, a fraction of the U.S.’s more than 1 million deaths. China’s Communist Party has celebrated its lower official death count as evidence of the superiority of its governance model.
In recent months, Chinese officials have maintained close contact with the World Health Organization, focusing on the alert level that the Geneva-based body has assigned for the Covid-19 pandemic, according to people familiar with the matter.
The WHO’s emergency committee meets once every three months to assess whether the pandemic still constitutes a “public health emergency of international concern.”
A WHO shift in declaration would give China more wiggle room for policy changes. Beijing could start to push for more aggressive easing measures and adjust the domestic narrative on Covid, effectively declaring victory in containing the virus, according to people familiar with the matter.
The WHO first declared a public health emergency of international concern in January 2020, and decided during its latest meeting, held in October, that it is still too early to lift the status. The next meeting is slated for January.
A WHO official said the agency doesn’t comment on private discussions with member states.
One plan under consideration in Beijing, the people said, would be to begin treating Covid-19 as a “Class B” infectious disease following any change in the WHO’s designation. China has been treating it as a Class A disease, which calls for stricter public-health measures.
Even with such a move, it could take China a much longer time—perhaps a year, the people said—to return to pre-pandemic levels of activity. The government wants to continue to monitor new variants closely to ensure that they don’t become more dangerous, they said.
Any further loosening of measures would be contingent on a boost in the elderly vaccination rate. Beijing is planning to launch a vaccination campaign later this year for vulnerable groups, aiming for 95% of people aged 60 or above to receive two doses, some of the people said. The latest government data, from early November, shows 86% of the elderly population had received two vaccine doses, compared with 90% for the broader population.
Another condition for a full reopening of its economy is to boost access to oral antivirals to treat Covid, the people said. Earlier this year, China’s drug regulator granted approval for Azvudine, an HIV drug developed by Chinese drugmaker Henan Genuine Biotech Co., to be used for treating Covid. Drug regulators have also approved Pfizer Inc.’s Paxlovid drug.
The National Health Commission responded to a request for comment by referring to remarks made during its Saturday press conference.
There have been some signs of a shift in China’s posture on Covid in recent months. In September, Mr. Xi visited Central Asia, making his first trip outside the country since Covid began spreading in the central Chinese city of Wuhan in early 2020. The Chinese leader has also begun receiving foreign heads of state in Beijing and is expected to attend a summit of leaders from the Group of 20 nations in Indonesia next week.
Still, Beijing has been careful to rein in expectations of a rapid shift, including in the Saturday press conference. In a string of pointed commentaries last month, Communist Party mouthpiece the People’s Daily called for confidence and patience with Beijing’s zero-Covid strategy. Health officials have urged local governments to build quarantine hospitals to prepare for rebounding infections. Shanghai, for example, is building a quarantine facility that can house more than 3,000 people at a cost of just under $200 million, state media reported.
“All the signs are pointing to the beginning of preparation for an eventual reopening, especially given the rising cost of the ‘dynamic zero-Covid’ policy for the economy,” Goldman Sachs economists said in a Monday note. “The actual reopening is still months away as elderly vaccination rates remain low and case fatality rates appear high among those unvaccinated based on Hong Kong official data.”
—Drew Hinshaw contributed to this article.
Write to Keith Zhai at keith.zhai@wsj.com
China Weighs Zero-Covid Exit But Proceeds With Caution and Without Timeline
SINGAPORE—Chinese leaders are considering steps toward reopening after nearly three years of tough pandemic restrictions but are proceeding slowly and have set no timeline, according to people familiar with the discussions.
Chinese officials have grown concerned about the costs of their zero-tolerance approach to smothering Covid outbreaks, which has resulted in lockdowns of cities and whole provinces, crushing business activity and confining hundreds of millions of people at home for weeks and sometimes months on end. But they are weighing those against the potential costs of reopening on public health and support for the Communist Party.
As a result, they are proceeding cautiously despite the deepening impact of the Covid policies, the people said, pointing to a long path to anything approaching pre-pandemic levels of activity, with the timeline stretching to sometime near the end of next year.
The uncertainty around China’s Covid-19 strategy has led to a guessing game in the financial markets, with some looking for any sign that China would begin easing its Covid policies. China’s Communist Party congress last month, when Chinese leader Xi Jinping claimed a third term, had once been viewed as a potential turning point in its battle against Covid, but little has changed in the country’s approach to containing Covid.
China’s leaders are worried that a surge in Covid infections, hospital admissions and deaths could undermine confidence in the ruling Communist Party’s legitimacy.
PHOTO: TINGSHU WANG/REUTERS
On Saturday, officials from China’s National Health Commission again reaffirmed their commitment to a firm “zero-Covid” strategy, which they described as essential to “protect people’s lives.”
Some progress is being made on relaxing border controls for inbound travelers from abroad. Beijing is likely to further cut the number of hotel quarantine days required of incoming travelers by early next year, to a total of seven days, say people involved in discussions, from a current policy of seven days in a quarantine facility followed by three days of home monitoring.
Domestically, officials have informed retail businesses that the frequency of PCR testing—a staple of China’s Covid regime—could be reduced as soon as this month, in part because of the high cost of mass testing, according to people familiar with the matter. The people said the government is planning to reduce the thousands of PCR testing stations that have been set up across the country as part of the campaign to institutionalize testing, citing the cost.
Still, the leadership has found it difficult to enact broader relaxation measures this year, the people said. Many of the measures will remain. The country will still move aggressively to stamp out even small outbreaks, through mass testing and lockdowns. People will still need to use health codes on their phones to access public spaces, and travelers entering the country will face quarantines and rounds of Covid tests.
A combination of new viral variants, an underequipped public healthcare system and the impending approach of winter has left Beijing worried that a potential surge in Covid infections, hospital admissions and deaths could undermine confidence in the ruling Communist Party’s legitimacy.
Chinese health officials have been closely monitoring the fatality rates and public reactions in Hong Kong, Japan and South Korea, which share cultural roots with China and where governments had until recently imposed similar measures, the people said.
“The reopening in China will be carried out in an orderly manner. It will start gradually depending on the geographic areas and sectors, and it will be different from what we’ve seen in the West,” said one of the people involved in discussions. For example, the government could decide to implement less stringent measures in cities that are major business hubs.
While some have questioned the accuracy of China’s official figures, health experts say the country’s Covid fatality rate has been much lower than in much of the West due to its strict measures. Officially, China has recorded roughly 5,000 Covid-19 deaths, a fraction of the U.S.’s more than 1 million deaths. China’s Communist Party has celebrated its lower official death count as evidence of the superiority of its governance model.
In recent months, Chinese officials have maintained close contact with the World Health Organization, focusing on the alert level that the Geneva-based body has assigned for the Covid-19 pandemic, according to people familiar with the matter.
The WHO’s emergency committee meets once every three months to assess whether the pandemic still constitutes a “public health emergency of international concern.”
A WHO shift in declaration would give China more wiggle room for policy changes. Beijing could start to push for more aggressive easing measures and adjust the domestic narrative on Covid, effectively declaring victory in containing the virus, according to people familiar with the matter.
The WHO first declared a public health emergency of international concern in January 2020, and decided during its latest meeting, held in October, that it is still too early to lift the status. The next meeting is slated for January.
A WHO official said the agency doesn’t comment on private discussions with member states.
One plan under consideration in Beijing, the people said, would be to begin treating Covid-19 as a “Class B” infectious disease following any change in the WHO’s designation. China has been treating it as a Class A disease, which calls for stricter public-health measures.
Even with such a move, it could take China a much longer time—perhaps a year, the people said—to return to pre-pandemic levels of activity. The government wants to continue to monitor new variants closely to ensure that they don’t become more dangerous, they said.
Any further loosening of measures would be contingent on a boost in the elderly vaccination rate. Beijing is planning to launch a vaccination campaign later this year for vulnerable groups, aiming for 95% of people aged 60 or above to receive two doses, some of the people said. The latest government data, from early November, shows 86% of the elderly population had received two vaccine doses, compared with 90% for the broader population.
Another condition for a full reopening of its economy is to boost access to oral antivirals to treat Covid, the people said. Earlier this year, China’s drug regulator granted approval for Azvudine, an HIV drug developed by Chinese drugmaker Henan Genuine Biotech Co., to be used for treating Covid. Drug regulators have also approved Pfizer Inc.’s Paxlovid drug.
The National Health Commission responded to a request for comment by referring to remarks made during its Saturday press conference.
There have been some signs of a shift in China’s posture on Covid in recent months. In September, Mr. Xi visited Central Asia, making his first trip outside the country since Covid began spreading in the central Chinese city of Wuhan in early 2020. The Chinese leader has also begun receiving foreign heads of state in Beijing and is expected to attend a summit of leaders from the Group of 20 nations in Indonesia next week.
Still, Beijing has been careful to rein in expectations of a rapid shift, including in the Saturday press conference. In a string of pointed commentaries last month, Communist Party mouthpiece the People’s Daily called for confidence and patience with Beijing’s zero-Covid strategy. Health officials have urged local governments to build quarantine hospitals to prepare for rebounding infections. Shanghai, for example, is building a quarantine facility that can house more than 3,000 people at a cost of just under $200 million, state media reported.
“All the signs are pointing to the beginning of preparation for an eventual reopening, especially given the rising cost of the ‘dynamic zero-Covid’ policy for the economy,” Goldman Sachs economists said in a Monday note. “The actual reopening is still months away as elderly vaccination rates remain low and case fatality rates appear high among those unvaccinated based on Hong Kong official data.”
—Drew Hinshaw contributed to this article.
Write to Keith Zhai at keith.zhai@wsj.com
是一个新加坡华裔记者写的，八成是🛸来帮助中共舆论维稳的，资本在外逃，所以要放点假消息救市。
vpn789
灰名单
不是华尔街日报准，而是有人提供内幕消息，比如这篇文章WSJ网站作为独家新闻，如果引用的知情人士属实，说明有这个讨论。
华尔街日报之前还说，中共知情人爆料习近平出国，结果没出
华尔街日报确实有内幕消息，是中共高层放料的传声筒，料有真有假，中共放出假料是害怕外资撤离
并不是华尔街日报的所有报道都是真的，现在冬天到了病毒会更猖獗，所以习近平更加不会放开疫情
国务院都说了要贯彻清零你还在这里做梦
华尔街日报确实有内幕消息，是中共高层放料的传声筒，料有真有假，中共放出假料是害怕外资撤离
并不是华尔街日报的所有报道都是真的，现在冬天到了病毒会更猖獗，所以习近平更加不会放开疫情
国务院都说了要贯彻清零你还在这里做梦
我建议即使是华尔街日报这样的媒体也最好看看作者是谁，因为爆料人应该只会和特定的记者编辑有交流，这次这位撰稿人的内部消息不一定是之前爆习上李下那位。
“Chinese leaders are considering steps toward reopening after nearly three years of tough pandemic restrictions but are proceeding slowly and have set no timeline, according to people familiar with the discussions.”
leaders是复数，可信度不高，鉴定完毕
leaders是复数，可信度不高，鉴定完毕
降低核酸检测真是想多了,郑州这两天刚开始装模作样解封就又爆炸一波，对于奥秘可容，防疫不彻底等于彻底不防疫
习近平就是一个见爹说嗲话、见鬼说鬼话的两面人、崇美媚美跪美的卖国贼！
这个傻逼接下来打算亲自打脸，这世界没见过如此精神分裂的猪
“精神错乱是一遍又一遍地重复同一件事而期待不同的结果”
“精神错乱是一遍又一遍地重复同一件事而期待不同的结果”
华尔街这帮人在中概股里面的钱还没撤完呢，尤其是高盛。中选后有可能又是一轮下跌，所以你说急不急。没什么可分析的，就是单纯的找人接盘而已，不要想多了。
WSJ大外宣，肯定是习近平自己放料
习近平为了外资，真是没少花钱贿赂华尔街日报
习近平为了外资，真是没少花钱贿赂华尔街日报
有可能会“外紧内松”，毕竟还要引Sinitic族群入PRC实控范围，还有让外资尽可能晚离开，也有可能真全放，不过短期可能性小，毕竟清零宗还要为了面子死撑------至少装作还在清零
放点风出来，毕竟一波连任全员包人大食堂啥的gei韭菜和外资都吓够呛吧
希望人民的苦难能少一点！
看原文要会员，我没办法解锁全文。如果这次的知情人士也是党内高层出来放风的话，应该比较准了，至少表达了他们内部的意思是正在考虑。
不过这篇报道的标题倒是有一些玩味，也增加了一点不确定性，可以看出来wsj并不想把话说死：
China Weighs Zero-Covid Exit But Proceeds With Caution and Without Timeline
大概意思是：正在考虑，还没有确定的时间？
ps：感谢网友po上原文，怎么看完之后感觉这更像是一篇分析而不是爆料？
看原文要会员，我没办法解锁全文。如果这次的知情人士也是党内高层出来放风的话，应该比较准了，至少表达了他们内部的意思是正在考虑。
不过这篇报道的标题倒是有一些玩味，也增加了一点不确定性，可以看出来wsj并不想把话说死：
China Weighs Zero-Covid Exit But Proceeds With Caution and Without Timeline
大概意思是：正在考虑，还没有确定的时间？
ps：感谢网友po上原文，怎么看完之后感觉这更像是一篇分析而不是爆料？
7月份的时候全国都在嘲笑日本医疗崩溃呢，为的就是抓个典型
科学的分析要对应科学的社会，要知道这疫情根本就是政治问题，不是什么公共健康问题，还分析医疗资源挤兑病毒变种后面一大堆话语简直就是扯淡。
没有钱，打开不了WSJ原文 。
紫数不定紫数不定紫数不定紫数不定紫数不定
紫数不定紫数不定紫数不定紫数不定紫数不定
个人意见是讨论肯定是在讨论的，而且必定是在准备计划的
否则不会几乎所有主流外媒都陆续的放出了相同的风，彭博社、WSJ、路透都爆了，应该是确有其事的。焦点应该在于放松的程度和速度，肯定是非常缓慢的
否则不会几乎所有主流外媒都陆续的放出了相同的风，彭博社、WSJ、路透都爆了，应该是确有其事的。焦点应该在于放松的程度和速度，肯定是非常缓慢的
他们什么时候在乎过执政的合法性了？难道还真想着有人能拉它下去？
华尔街不是中共传声筒而是习近平的传声筒
习近平这个畜生做事情只为了面子 所以要从他的角度分析 因为放松清零和继续开放属于打自己脸 所以现在放这个话只能认为是二十大后经济情况非常不容乐观 崩盘在即的那种不乐观 港股A股汇市债市楼市全都要爆掉完全托不住的那种不乐观
所以它现在才放低身段想先稳住局面 估计它只是想让明年两会自己能坐稳前 这些都别崩盘 可能计划着过了两会就翻脸
习近平这个畜生做事情只为了面子 所以要从他的角度分析 因为放松清零和继续开放属于打自己脸 所以现在放这个话只能认为是二十大后经济情况非常不容乐观 崩盘在即的那种不乐观 港股A股汇市债市楼市全都要爆掉完全托不住的那种不乐观
所以它现在才放低身段想先稳住局面 估计它只是想让明年两会自己能坐稳前 这些都别崩盘 可能计划着过了两会就翻脸